Key Quantitative Figures (Q1 FY27)

Operating Results (₹ lakhs):

  • Gross Premium Written: 2,73,086
  • Net Premium Written: 2,09,419
  • Premium Earned (Net): 2,00,696
  • Income from Investments (net): 35,183
  • Other Income: 57 (Comprising ₹20 for KMP remuneration, ₹37 others)
  • Total Income: 2,35,936
  • Commissions & Brokerage: 61,512
  • Operating Expenses: 19,198 (Employees: ₹9,910; Other: ₹9,288)
  • Incurred Claims (net): 1,04,654
  • Total Expense: 2,28,897
  • Underwriting Profit/(Loss): (28,201)
  • Operating Profit/(Loss): 7,039

Non-Operating Results & Bottom Line (₹ lakhs):

  • Income in Shareholders' Account: 13,862 (Transfer from Policyholders: ₹7,039; Investment Income: ₹6,823; Other: ₹0)
  • Other Expenses: 2,395
  • Profit Before Tax: 11,545
  • Provision for Tax: 2,906
  • Profit After Tax: 8,639

Earnings Per Share (Face Value ₹10):

  • Basic & Diluted EPS: ₹0.93

Balance Sheet & Capital (As on 30th June 2026):

  • Paid-up Equity Capital: ₹92,460 lakhs
  • Reserves & Surplus: ₹3,81,096 lakhs
  • Borrowings: ₹35,000 lakhs
  • Total Assets: Not explicitly summed but components detailed.

Key Analytical Ratios:

  • Solvency Ratio: 2.43
  • Expenses of Management Ratio: 39.0%
  • Incurred Claim Ratio: 73.3%
  • Net Retention Ratio: 76.7%
  • Combined Ratio: 112.3%

Segment-Wise Performance (Q1 FY27 - Underwriting Profit/Loss in ₹ lakhs)

The company reported segmental results for Fire, Marine, Health (Retail, Group/Corporate, Government), Motor, Miscellaneous (Retail, Group/Corporate), and Crop.

  • Fire: Profit of ₹1,927
  • Marine: Profit of ₹421
  • Health Retail: Loss of ₹(343)
  • Health Group/Corporate: Loss of ₹(5,143)
  • Health Government: Profit of ₹1,546
  • Motor: Loss of ₹(28,209)
  • Miscellaneous Retail: Profit of ₹31
  • Miscellaneous Group/Corporate: Profit of ₹995
  • Crop: Profit of ₹574

Dates of Action

  • Board Meeting: Held on 23rd July 2026 (commenced 4:36 PM, concluded 5:39 PM).
  • Quarter End: Financial results are for the quarter ended 30th June 2026.
  • AGM Rescheduling: The 10th AGM was rescheduled from Thursday, 6th August 2026 at 3:00 PM to Tuesday, 18th August 2026 at 4:00 PM (to be held via VC/OAVM).
  • Revised AGM & E-voting Schedule:
  • Cut-off date for e-Voting: Tuesday, August 11, 2026
  • Commencement of remote e-Voting: Friday, August 14, 2026 at 9:00 a.m. (IST)
  • Conclusion of remote e-Voting: Monday, August 17, 2026 at 5:00 p.m. (IST)

Parties Involved

  • Company Management & Board: Responsible for preparation and approval of results.
  • Joint Statutory Auditors: PKF Sridhar and Santhanam LLP and Kirtane & Pandit LLP issued the limited review report.
  • Appointed Actuary: Certified the valuation of IBNR, IBNER, and PDR liabilities.
  • Regulators: SEBI (Listing Regulations), IRDAI (Insurance Regulations).
  • Shareholders: Recipients of the AGM notice.
  • E-voting Provider: NSDL.
  • Stock Exchanges: BSE Limited and National Stock Exchange of India Limited (NSE).

Purpose / Rationale

The disclosure is a mandatory regulatory requirement to inform the stock exchanges and shareholders of the company's financial performance for the quarter and a change in the corporate calendar.

Other Material Disclosures

1. ESOP Allotment: The company allotted 1,04,047 equity shares (FV ₹10) during the quarter pursuant to the exercise of employee stock options.

2. Excess Expenses: The Company's expenses relating to the insurance business for the quarter ended June 30, 2026, are in excess of IRDAI regulatory limits. The company has sought forbearance for FY26.

3. Ind AS Forbearance: IRDAI granted the company an exemption from preparing Ind AS financial statements until March 31, 2027. The Q1 FY27 results are prepared under the existing accounting framework.

4. Scheme of Amalgamation: The board had previously approved a scheme to amalgamate Go Digit Infoworks Services Pvt. Ltd. (Transferor) with the company (Transferee).

  • BSE and NSE have issued 'no adverse observation' letters (dated April 22, 2026).
  • Approvals are pending from IRDAI, CCI, and NCLT.
  • The Appointed Date and Effective Date are the same.

5. Shareholder Complaints: One investor complaint was received and resolved during the quarter; none were pending at the start or end of the period.

Capital Structure Impact

The allotment of 1,04,047 ESOPs increased the paid-up capital from ₹92,450 lakhs (as of Mar'26) to ₹92,460 lakhs (as of Jun'26).

Footnotes & Qualifications

  • The figures for the quarter ended March 31, 2026 (Q4 FY26), are balancing figures between audited annual figures and previously published unaudited nine-month figures.
  • The review by auditors provides moderate assurance, not an audit opinion.
  • The actuarial valuation of liabilities (IBNR, IBNER, PDR) is based on the Appointed Actuary's certificate.